Jun 22, 2020 7:30 am EDT Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35
Jun 18, 2020 7:30 am EDT Heat Biologics Announces Initiation of the Lead Clinical Trial Site for PTX-35
Jun 08, 2020 7:30 am EDT Heat Biologics Announces FDA Clearance of Investigational New Drug (IND) Application for PTX-35
May 29, 2020 8:00 am EDT Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
May 27, 2020 8:00 am EDT Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine
May 14, 2020 8:00 am EDT Positive Survival Data from Phase 2 Lung Cancer Trial Accepted for Presentation at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
May 11, 2020 8:00 am EDT Heat Biologics Provides Clinical Update; Reports Continued Progress Advancing HS-110
Apr 29, 2020 8:37 am EDT Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones